Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma

M. Schaapveld; B.M.P. Aleman; A.M. van Eggermond; C.P.M. Janus; A.D.G. Krol; R.W.M. van der Maazen; J. Roesink; J.M.M. Raemaekers; J.P. de Boer; J.M. Zijlstra; G.W. van Imhoff; E.J. Petersen; P.M.P. Poortmans; M. Beijert; M.L. Lybeert; I. Mulder; O. Visser; M.W.J. Louwman; I.M. Krul; P.J. Lugtenburg; F.E. van Leeuwen

doi:https://doi.org/10.1056/NEJMoa1505949

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma

M. Schaapveld, B.M.P. Aleman, A.M. van Eggermond, C.P.M. Janus, A.D.G. Krol, R.W.M. van der Maazen, J. Roesink, J.M.M. Raemaekers, J.P. de Boer, J.M. Zijlstra, G.W. van Imhoff, E.J. Petersen, P.M.P. Poortmans, M. Beijert, M.L. Lybeert, I. Mulder, O. Visser, M.W.J. Louwman, I.M. Krul, P.J. LugtenburgF.E. van Leeuwen

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

448 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2499-2511
Journal	New England journal of medicine
Volume	373
Issue number	26
DOIs	https://doi.org/10.1056/NEJMoa1505949
Publication status	Published - 2015

Access to Document

https://doi.org/10.1056/NEJMoa1505949

Cite this

Schaapveld, M., Aleman, B. M. P., van Eggermond, A. M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., Roesink, J., Raemaekers, J. M. M., de Boer, J. P., Zijlstra, J. M., van Imhoff, G. W., Petersen, E. J., Poortmans, P. M. P., Beijert, M., Lybeert, M. L., Mulder, I., Visser, O., Louwman, M. W. J., Krul, I. M., ... van Leeuwen, F. E. (2015). Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. New England journal of medicine, 373(26), 2499-2511. https://doi.org/10.1056/NEJMoa1505949

@article{824ee0bee0484c0ca3659464424fae7e,

title = "Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma",

author = "M. Schaapveld and B.M.P. Aleman and {van Eggermond}, A.M. and C.P.M. Janus and A.D.G. Krol and {van der Maazen}, R.W.M. and J. Roesink and J.M.M. Raemaekers and {de Boer}, J.P. and J.M. Zijlstra and {van Imhoff}, G.W. and E.J. Petersen and P.M.P. Poortmans and M. Beijert and M.L. Lybeert and I. Mulder and O. Visser and M.W.J. Louwman and I.M. Krul and P.J. Lugtenburg and {van Leeuwen}, F.E.",

year = "2015",

doi = "https://doi.org/10.1056/NEJMoa1505949",

language = "Undefined/Unknown",

volume = "373",

pages = "2499--2511",

journal = "New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "26",

}

Schaapveld, M, Aleman, BMP, van Eggermond, AM, Janus, CPM, Krol, ADG, van der Maazen, RWM, Roesink, J, Raemaekers, JMM, de Boer, JP, Zijlstra, JM, van Imhoff, GW, Petersen, EJ, Poortmans, PMP, Beijert, M, Lybeert, ML, Mulder, I, Visser, O, Louwman, MWJ, Krul, IM, Lugtenburg, PJ & van Leeuwen, FE 2015, 'Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma', New England journal of medicine, vol. 373, no. 26, pp. 2499-2511. https://doi.org/10.1056/NEJMoa1505949

TY - JOUR

T1 - Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma

AU - Schaapveld, M.

AU - Aleman, B.M.P.

AU - van Eggermond, A.M.

AU - Janus, C.P.M.

AU - Krol, A.D.G.

AU - van der Maazen, R.W.M.

AU - Roesink, J.

AU - Raemaekers, J.M.M.

AU - de Boer, J.P.

AU - Zijlstra, J.M.

AU - van Imhoff, G.W.

AU - Petersen, E.J.

AU - Poortmans, P.M.P.

AU - Beijert, M.

AU - Lybeert, M.L.

AU - Mulder, I.

AU - Visser, O.

AU - Louwman, M.W.J.

AU - Krul, I.M.

AU - Lugtenburg, P.J.

AU - van Leeuwen, F.E.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1056/NEJMoa1505949

DO - https://doi.org/10.1056/NEJMoa1505949

M3 - Article

C2 - 26699166

SN - 0028-4793

VL - 373

SP - 2499

EP - 2511

JO - New England journal of medicine

JF - New England journal of medicine

IS - 26

ER -